Table 1.
Demographics of patients with and without post-COVID-19 symptoms.
| Clinical Variables | No Post-COVID-19 Symptoms (14) | Post-COVID-19 Symptoms (10) | P-value |
|---|---|---|---|
| Age | 60.1 ± 12.2 (14) | 54.5 ± 12.5 (10) | 0.306 |
| Sex (Male) | 85.7% (12/14) | 50.0% (5/10) | 0.085 |
| Body Mass Index | 30.6 ± 6.5 (12) | 28.7 ± 6.9 (7) | 0.526 |
| Admitted to ICU (Yes) | 28.6% (4/14) | 30.0% (3/10) | 1.000 |
| Smoker (Yes) | 25.0% (3/12) | 0.0% (0/7) | 0.263 |
| Comorbidities | |||
| Asthma (Yes) | 14.3% (2/14) | 10.0% (1/10) | 1.000 |
| COPD (Yes) | 0.0% (0/14) | 10.0% (1/10) | 0.417 |
| Chronic Lung Disease (Yes) | 21.4% (3/14) | 10.0% (1/10) | 0.615 |
| Hypertension (Yes) | 64.3% (9/14) | 10.0% (1/10) | 0.013 |
| Diabetes (Yes) | 50.0% (7/14) | 0.0% (0/10) | 0.019 |
| Immunosuppressed (Yes) | 21.4% (3/14) | 10.0% (1/10) | 0.615 |
| Worst Laboratory Values | |||
| Highest %Neutrophil | 80.3 ± 7.9 (14) | 77.0 ± 8.0 (10) | 0.279 |
| Lowest %Lymphocyte | 6.8 ± 3.7 (14) | 6.8 ± 2.9 (10) | 0.838 |
| Highest %Monocyte | 8.6 ± 2.6 (14) | 9.2 ± 1.7 (10) | 0.364 |
| Lowest Platelets (103/µL) | 244.4 ± 120.9 (14) | 228.4 ± 100.3 (10) | 0.884 |
| Highest Estimated SOFA Score | 3.3 ± 2.6 (14) | 4.1 ± 3.1 (10) | 0.456 |
| Highest WHO COVID-19 Score | 5.6 ± 1.4 (14) | 6 ± 1.4 (10) | 0.360 |
| Hospitalized Duration (Days) | 16.4 ± 14.8 (14) | 14.9 ± 14.5 (10) | 0.907 |
| Follow-up Metrics | |||
| Discharge to Follow-up (Days) | 53.6 ± 13.7 (14) | 45.3 ± 15 (10) | 0.135 |
| Mobility Score | 0.1 ± 0.3 (14) | 0.9 ± 0.9 (10) | 0.005 |
| Self-Care Score | 0 ± 0 (14) | 0.2 ± 0.6 (10) | 0.272 |
| Usual Activity Score | 0.1 ± 0.3 (14) | 0.4 ± 0.8 (10) | 0.333 |
| Pain and Discomfort Score | 0.2 ± 0.4 (14) | 1.1 ± 1 (10) | 0.012 |
| Anxiety and Depression Score | 0.1 ± 0.4 (14) | 0.4 ± 0.7 (10) | 0.341 |
| Breathlessness Score | 0.4 ± 0.5 (14) | 1.6 ± 0.8 (10) | 0.001 |
| Difficulty Carrying 10 Pounds | 0.1 ± 0.4 (14) | 0.7 ± 0.9 (10) | 0.113 |
| Difficulty Walking Across Room | 0 ± 0 (14) | 0.2 ± 0.4 (10) | 0.099 |
| Difficulty Climbing 10 Stairs | 0 ± 0 (14) | 0.7 ± 0.8 (10) | 0.004 |
| Difficulty Transferring from Chair to Bed | 0.1 ± 0.3 (14) | 0.3 ± 0.7 (10) | 0.359 |
| Number of Falls in Past Year | 0.1 ± 0.4 (14) | 0.1 ± 0.3 (10) | 0.798 |
| Total Frailty Score | 1.2 ± 1.4 (14) | 6.6 ± 5.8 (10) | 0.002 |
| Poor Health Self-Rating | 15.7 ± 10.2 (14) | 26.6 ± 13.3 (10) | 0.051 |
For categorical variables, significance was tested using the Chi-squared test with Yates’s correction, or the Fisher’s exact test if any expected value was <5, and the percentage and fraction of patients fitting the category is displayed. For continuous variables, the Wilcoxon Rank-Sum test was used, and the mean ± standard deviation of the variable is displayed, with the number of patients assessed in brackets. Follow-up metric scores are discussed in Table S1 . The full set of assessed clinical variables, including non-significant differences in arrival values, other comorbidities, and treatments administered in hospital, are found in Table S2 . Significant p-values (p <0.05) are bolded.